Coronavirus disease 2019 (COVID-19) is often associated with skin lesions. Identification of the skin lesions related to COVID-19 is important for early diagnosis and better management of affected patients. The cutaneous manifestations of COVID-19 are classified into two major categories: inflammatory lesions (maculopapular erythematous rash, papulovesicular eruption, urticarial lesions, erythema multiforme-like) and vasculopathic reaction (livedo reticularis/livedo racemosa, petechiae/noninflammatory purpura and skin necrosis, acral lesions, cutaneous small-vessel vasculitis). In addition, mucocutaneous lesions are common in multisystem inflammatory syndrome in children with COVID-19. This chapter provides a description of each entity in terms of definition, clinical and pathological manifestations, etiopathogenesis, prognosis, treatment, and differential diagnoses.
CITATION STYLE
Abtahi-Naeini, B., & Fattah, M. (2021). COVID-19 and Dermatological Manifestations. In Atlas of Dermatology, Dermatopathology and Venereology: Cutaneous Infectious and Neoplastic Conditions and Procedural Dermatology (pp. 191–223). Springer International Publishing. https://doi.org/10.1007/978-3-319-53805-1_100
Mendeley helps you to discover research relevant for your work.